Empirical Financial Services LLC d.b.a. Empirical Wealth Management Invests $635,000 in CVS Health Corporation $CVS

Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new stake in shares of CVS Health Corporation (NYSE:CVS) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 8,428 shares of the pharmacy operator’s stock, valued at approximately $635,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Lion Street Advisors LLC increased its stake in CVS Health by 8.7% in the third quarter. Lion Street Advisors LLC now owns 9,093 shares of the pharmacy operator’s stock valued at $686,000 after purchasing an additional 730 shares during the last quarter. Bridgewater Advisors Inc. lifted its holdings in shares of CVS Health by 5.5% during the 3rd quarter. Bridgewater Advisors Inc. now owns 4,142 shares of the pharmacy operator’s stock worth $326,000 after acquiring an additional 217 shares during the period. New Millennium Group LLC acquired a new stake in shares of CVS Health in the third quarter worth approximately $62,000. Jupiter Asset Management Ltd. grew its holdings in CVS Health by 578.1% in the third quarter. Jupiter Asset Management Ltd. now owns 738,418 shares of the pharmacy operator’s stock valued at $55,669,000 after purchasing an additional 629,518 shares during the period. Finally, Persistent Asset Partners Ltd purchased a new position in CVS Health during the third quarter worth approximately $3,886,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on CVS shares. Piper Sandler restated an “overweight” rating and set a $101.00 price objective (up from $99.00) on shares of CVS Health in a report on Wednesday, December 10th. Morgan Stanley boosted their price target on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Sanford C. Bernstein restated a “market perform” rating and issued a $91.00 price objective on shares of CVS Health in a report on Tuesday, January 6th. UBS Group reiterated an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Finally, Mizuho raised their price target on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Nineteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Stock Up 0.4%

Shares of NYSE:CVS opened at $77.00 on Tuesday. The company has a market capitalization of $97.96 billion, a price-to-earnings ratio of 55.80, a price-to-earnings-growth ratio of 0.80 and a beta of 0.50. The company has a 50 day moving average of $78.47 and a two-hundred day moving average of $76.96. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the prior year, the firm earned $1.19 earnings per share. The business’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s payout ratio is 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.